MY01 develops the Continuous Compartmental Pressure Monitor (CCPM), a microsensor system that streams continuous compartment pressure data to a bedside monitor and mobile app to improve acute compartment syndrome (ACS) diagnosis. The device is designed to make ACS diagnosis more efficient and accurate by providing continuous pressure measurements rather than intermittent checks. MY01’s CCPM received FDA approval and was named a “breakthrough device” in 2021, and the product was launched in several major U.S. hospitals that year. The company is currently running multiple clinical trials with physicians in Canada. MY01 plans to use the new funding primarily to expand U.S. commercialization efforts and accelerate growth. The company was founded in March 2015 by Ed Harvey and is based in Montréal.

Total raised

$9M

Funding rounds

1

Latest round

Series A

Latest activity

Apr 2023